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Clinical outcomeAbstract Introduction: Tuberculosis (TB) is caused by Mycobacterium tuberculosis, primarily
affecting lungs. One-third of the world’s population is currently infected with the TB bacillus.
Tuberculosis is one of the three primary diseases of poverty. The risk of developing tuberculosis
is higher in immunocompromised persons and is a chronic debilitating disease.
Aims and objectives: To study the demographic features and clinical outcome of pulmonary
tuberculosis.
Materials and methods: A prospective study involving 72 pulmonary tuberculosis patients above
18 years.
Results: In our study 45 were below the age of 40 years with a mean age of 47 years ±12.39, with
a male to female ratio of 1.4:1.61; patients were from rural areas and 18 were labourers. Two were
HIV positive; fever was the main presenting complaint. Mean haemoglobin was 11.2 ± 2.48. Mean
ESR was 45.2 ± 12.55. Bronchoscopy was done in 13 patients and 4 had bronchoalveolar lavage
positive for AFB. All patients received a daily regimen of ATT. 4 were treated as Cat II, rest were
treated as Cat I. 64 patients (88.8%) were cured, 8 (11.1%) are on follow up. No resistance was
documented in any of the patients. Treatment related complications were seen in 43 (30.8%).
Conclusion: Tuberculosis most commonly occurs in younger patients, especially from rural
areas. Due to the low prevalence of HIV in Kashmir association with HIV was low. The Common-
est presentation was fever. Most patients had a good response to daily regimen and the most com-
mon drug related side effect was hepatitis.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Tuberculosis (TB) is an infectious disease caused by Mycobac-
terium tuberculosis. The disease primarily affects lungs. Over-
all, one-third of the world’s population is currently infected
with the TB bacillus. 5–10% of the people who are infected
Table 2 Occupational status of tuberculosis patients in our
study (n= 72).
Occupation Frequency (n= 72) Percentage (%)
Labourers 18 25
Students 14 19.5
Others (mostly elderly) 14 19.5
Housewives 13 18
Govt employee 10 14
Businessmen 3 4
Total 72 100
456 A. Nabi Koul et al.with TB bacilli (but who are not infected with HIV) become
sick or infectious at some time during their life. People with
HIV and tuberculosis infection are much more likely to
develop active tuberculosis. The risk for developing TB disease
is also higher in persons with diabetes, other chronic debilitat-
ing diseases leading to immune-compromised state, poor living
conditions, tobacco smokers, preexisting structural lung dis-
ease etc [1].
It can also affect other tissues of the body. The disease is
usually chronic with cardinal features like persistent cough
with or without expectoration, intermittent fever, loss of appe-
tite, weight loss, chest pain and haemoptysis [2]. In healthy
people, infection with M. tuberculosis often causes no symp-
toms, since the person’s immune system acts to ‘‘wall off”
the bacteria. Tuberculosis is one of the three primary diseases
of poverty along with AIDS and malaria [3].
The following proﬁle of patients should be screened for
tuberculosis:
 Persistent cough of 2 weeks or more or any duration in HIV
positive.
 Fever for more than 2 weeks.
 Unexplained night sweats.
 Unexplained weight loss (more than 1.5 kg in a month).
Aims and objectives
To study the demographic features, clinical presentation and
treatment outcome of pulmonary tuberculosis patients at
SKIMS, a tertiary care hospital in Kashmir valley.
Materials and methods
A prospective study of tuberculosis patients was conducted in
the Infectious Disease Department, Division of Internal Med-
icine, Sher-I-Kashmir Institute of Medical Sciences, Soura, Sri-
nagar from June 2013 to May 2015. Tuberculosis patients who
visited infectious disease clinic on OPD basis and patients who
were admitted in general medicine ward were taken up in this
study. For each patient clinical presentation, socio demo-
graphic proﬁle and outcome of treatment were recorded inter-
preted and analysed.
Inclusion criteria
All patients >18 years of age suspected of pulmonary tubercu-
losis were included.
Pulmonary tuberculosis was diagnosed on the basis of:Table 1 Demographic Characteristic of patients in our study (n=
Age Sex Residence Smoking Married
<40 >40 Male Female Rural Urban Yes No Yes No
45 27 42 30 61 15 26 46 45 27 Sputum smear for AFB (positive): two or more initial spu-
tum smear examination positive for AFB or one sputum
smear examination positive for AFB plus radiological
abnormalities consistent with active pulmonary tuberculosis
or one sputum smear positive for AFB plus sputum culture
positive for M. tuberculosis.
 Sputum smear for AFB (negative): those patients who had
BAL positive for AFB were also part of study.
All patients were subjected to the following investigations:
 CBC;
 Complete biochemistry including full LFT;
 Urine examination;
 Chest X-ray;
 ECG;
 USG abdomen;
 HIV;
 Sputum for AFB;
 Sputum culture for AFB, (as per clinical correlation);
 Broncho alveolar lavage for AFB staining/culture, (as per
clinical correlation);
 Gene Xpert and line probe assay (as per clinical
correlation).
Results and observation
In our study of 72 patients of pulmonary tuberculosis we
found 45 of them below age of 40 years with a mean age of
47 years ±12.39. 61 (84.7%) were from rural areas. 2 patients
were found to be HIV positive. 42 (58%) were males and
among them 18 (25%) were labourers. Family history of tuber-
culosis was in 16 patients (22.22%) Tables 1 and 2.
Fever was the presenting complaint in 59 patients (81.9%)
followed by cough and haemoptysis in 51 (70%) and 26 (19%)
respectively. Other features like weight loss, nausea, chest pain,72).
HIV status Alcohol/other addiction Family history
Positive Negative Absent Present Present Absent
2 70 72 0 16 56
Table 3 Presenting complaints of patients in our study (n= 72).
Complaints
No.
Fever Cough Hemoptysis Weight
loss
Nausea
vomiting
Chest
pain
BLN Cervical
swelling
Decreased
appetite
72 59
(81.9%)
51
(70.8%)
19 (26.4%) 8 (11.1%) 6 (8.3%) 7 (9.7%) 14
(19.4%)
1 (1.4%) 9 (12.5%)
P value 0.002 0.0001 0.0001 0.815 1.000 0.936 0.705 0.0001 0.832
Table 6 Treatment outcome of patients in our study (n= 72).
Outcome No. of patients
(n= 72)
Percentage
(%)
Cured 64 88.88
Default 0 0
Relapse 0 0
Died 0 0.0
Resistance documented (gene
Xpert/line probe assay)
0 0
On treatment 8 11.1
Total 72 100
Demography and clinical outcome of pulmonary tuberculosis 457breathlessness, cervical swelling, decreased appetite and pain
abdomen occurred less frequently Table 3.
In our study the USG chest/abdomen ﬁndings included
pleural effusion in 11 (23.9%) of cases (p valve of 0.056),
ascites in 6 (17.6%) of cases (p valve of 0.018), hep-
atosplenomegaly in 11 (35.5%) of cases (p valve of 1.000),
abdominal lymphadenopathy in 4 (18.2%) of cases (p valve
of 0.097), omental thickening in 2 (25.0%) of cases (p valve
of 0.714), and cervical lymphadenopathy in 3 (9.1%) of cases
(p valve of 0.0001), Table 4.
With regard to CECT chest/abdomen ﬁndings mediastinal
lymphadenopathy was seen in 13 (32.5%) of cases (p valve
0.714), pleural effusion in 7 (17.9%) of cases (p valve 0.009),
cavitary lesions 27 (87.1%) of cases (p valve 0.0001), consoli-
dation in 30 (45.5%)of cases (p valve 0.047), abdominal lym-
phadenopathy (LAP) in 5 (17.0%) of cases (p valve 0.023),
hepatosplenomegaly (HSM) in 3 (20.0%) of cases (p valve
0.264), omental thickening in 2 (1.8%) of cases (p valve
0.034), and cervical lymphadenopathy in 2 (7.7%) of cases (p
valve 0.0001) Table 5.
The treatment outcome of the patients in our study was
that; 64 (88.8%) were cured and 8 (11.1%) are on treatment.
4 patients were treated as defaulters (Cat II WHO) rest were
treated as Cat I WHO with a daily regime of ATT. In our
study there was no relapse and there were no defaulters as
shown in Table 6.
In our study, the treatment related complications were; 23
(16.5%) patients had ATT induced hepatitis, 8 (5.7%) had
hyperuricemia, 7 (5.04%) had gastritis, 4 (2.88%) hadTable 4 USG ﬁndings in patients in our study (n= 72).
USG ﬁndings Pleural eﬀusion Hepato splenomegaly Abdominal ly
Present 11 (23.9) 11 (35.5%) 4 (18.2%)
Absent 61 (39.6%) 61 (36.1%) 68 (38.2%)
p value 0.056 1.00 0.097
Table 5 CT ﬁndings in patients in our study (n= 72).
CT
ﬁndings
Mediastinal
lymphade -
nopathy
Pleural
eﬀusion
Cavitatory
lesion
Consolidation
Present 13 (32.5%) 7 (17.9% 27 (87.1%) 30 (45.5%)
Absent 59 (36.9%) 65
(40.4%)
45 (26.6%) 41 (30.8%)
p value 0.714 0.009 <0.0001 0.047nausea/vomiting, and 1 (0.72%) had neuropsychiatric manifes-
tation Table 7.
All the patients, underwent baseline investigations, the
results were; Hb was 11.2 ± 2.48 g/dl, TLC count was 7.03
± 2.96 mm3, and platelet count was 235.27 ± 100 mm3. Ery-
throcyte sedimentation rate was 45.2 ± 12.55 mm h. KFT/
LFT were as per Table 8.
Bronchoscopy was done in a total of 13 patients out of
which bronchoalveolar lavage was positive for AFB in 4
patients and TBLB was done as described in Table 9.
In our study, 35 (48.6%) patients had underlying comorbid-
ity, 14 (20.8.5%) had hypertension, 7 (9.7%) had diabetes, 1
(1.38%) had rheumatoid arthritis, 1 (1.38%) had chronic renal
failure, 4 (5.5% had hypothyroidism, 7 (9.7%) had COPD, 1
(1.38%) had Ca lung as shown in Table 10.mphadenopathy Omental thickening Cervical lymphadenopathy
2 (25.0%) 3 (9.1%)
70 (36.5%) 69 (41.3%)
0.714 <0.0001
Abdominal
lymphaden-
opathy
Hepato -
splenome-
galy
Omental
thickening
Cervical
lymphadenopathy
5 (17.0%) 3 (20.0%) 2 (1.8%) 2 (7.7%)
67 (39.2%) 69 (37.3%) 70 (38.1%) 70 (40.2%)
0.023 0.264 0.034 0.001
Table 7 Treatment related complications in patients in our
study (n= 72).
Treatment related
complications
No. of patients
(n= 72)
Percentage
(%)
ATT induced hepatitis 23 16.5
Hyperuricemia 8 5.7
Gastritis 7 5.04
Nausea/vomiting 4 2.88
Neuropsychiatric
complications
1 0.720
Total 43 30.84
Table 10 Comorbidities of tuberculosis patients in our study
(n= 72).
Comorbities No of cases Percentage (%)
Hypertension 15 20.8
Diabetes 7 9.7
Rheumatoid arthritis 1 1.38
Chronic renal failure 1 1.38
Hypothyroidism 4 5.5
COPD 7 9.7
Ca. Lung 1 1.38
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The present study was conducted in the Infectious disease divi-
sion of General Medicine Department, Sheri-I-Kashmir Insti-
tute of Medical Sciences, Jammu and Kashmir. In this study 72
patients were enrolled and it was a prospective hospital based
study.
The present study, comprised of 72 patients out of which 42
(58.3%) were males and 30 (41.6%) were females with a male
to female ratio of 1.4:1. Most of our study group patients
(62%) belonged to the age group of 18–40 years of age with
mean age of 47 years ±12.39 (Table 1) and most of the
patients were labourers 18 (25%) followed by student 14
(19.5%). 14 (19.5%) were elderly and not educated, 13
(18%) were housewives, (14%) were employee and 3 (4%)
were businessmen. A study conducted by Ogboi et al. [4] atTable 8 Baseline characteristic of tuberculosis patients in our stud
Baseline investigations Minimum Max
Hb 2.30 g/dl 17.6
TLC 4.7  103/ul 18.74
ESR mm/hr 10 75
Neutrophils 40.00% 98.00
Lymphocytes 2.00% 58.00
PLT 14  103/ul 530 
Urea (mg/dl) 11 240
Creatinine (mg/dl) 0.02 11.60
Bilirubin (mg/dl) 0.02 1.55
AST (U/L) 5 110
ALT (U/L) 10 129
ALP 51 240
Protein (g/dl) 3.5 8.73
Albumin (g/dl) 2.1 5.7
LDH (U/L) 67 345
Glucose (mg//dl) 65 201
Table 9 Bronchoscopy and BAL analysis.
HPE Caseous necrosis
(%)
Chronic granulomatosis
lymphadenitis (%)
Bronchoscopy
(n= 13)
1 (7.69%) 1 (7.69%)Nigeria found that out of 694 cases 200 (28.9%) were unem-
ployed and 79 (11.4%) were students, 154 (22.1%) were arti-
sans, and 168 (24.2%) were not educated. The results were
also comparable with a study conducted by Gebretsadik Berhe
et al. [5].
In our study majority of the patients were from rural areas.
Majority of the patients from rural areas (64.7%) were also
seen by Mengistuendris et al. [6]. In our study, 26 (36%) were
smokers and 46 (63.8.0%) were non smokers (Table 1). In a
study conducted by Jianming wang et al. [7], the proportion
of cigarette smoking was 54.6%, and in a study conducted
by l. Burnet et al. in South Africa, they have seen 56% and
60% of patients with active and latent TB infection were smok-
ers [8].
In our study, 45 (63%) were married and 27 (36.0%) were
unmarried, compared to a study done by Onyebuchi Step-
phanie Ofoegbu et al. in Nigeria where they have found that
57% of the study population were married [9].y (n= 72).
imum Mean Standard deviation
g/dl 11.2 2.48
 103/ul 7.03 2.96
45.2 12.55
% 71.11 11.63
% 19.98 10.71
103/ul 235.27 100.0
34.31 30.3
0.96 1.23
.56 0.35
32.98 16.64
35.29 15.9
112.26 37.88
6.61 .868
4.14 .735
215.63 51.97
104.33 19.3
Langerhans type giant
cells (%)
Non caseating
granulomas (%)
AFB
staining
1 (7.69%) 0% 4 (2%)
Demography and clinical outcome of pulmonary tuberculosis 459In our study, 2 (2.77%) were HIV positive. The seropreva-
lence of HIV among TB patients in a study conducted by Bahl,
Singh et al. in Jammu and Kashmir was 1.6% [10]. A study
conducted by Mubarik et al. [11] found that out of 1141
patients tested, 26 proved to have HIV 1 infection with no case
of HIV 2 detected. More than 42% were non Kashmiris.
Heterosexual transmission was the commonest with married
out numbering unmarried. However a study conducted by
Acharyal [12] found that out of 250 cases of TB admitted, 25
cases (10%) were diagnosed as HIV positive.
A study conducted by Acharya et al. [12] found that cough
with expectoration in 128 (51.2%), breathlessness 99 (39.6%)
and fever 91 (36.4%) were the chief presenting complaints,
Another study conducted by Bras et al. [13], found that most
common sign and symptom on admission was weight loss
(74.5%), fever (53.8%) and productive cough (43.2%). In
our study the most common presentation on admission was:
fever in 59 (81.9%) of cases (p valve 0.002), cough 51
(70.8%) of cases (p valve 0.0001), hemoptysis in 19 (26.4%)
of cases (p valve 0.0001), and cervical swelling in 1 (1.4%) of
cases (p valve 0.0001). Our study was concordant with a study
conducted by Ismail et al. [14].
Baseline investigations revealed a mean haemoglobin, ESR
and total leucocyte count of 11.2, 45.2 and 7.03 respectively
with minimum and maximum of these investigations 2.3, 10,
4.7 and 17.6, 75, 18.74 respectively. The minimum neutrophil
count was 40.00% and the maximum was 98.00% with a mean
of 71.11 ± 11.63 while as minimum lymphocyte count was
2.00% and the maximum was 58.00% with a mean of 19.98
± 10.71. Our results are comparable with a study conducted
by Singh, Ahluwalia et al. [15] and with a study conducted
by Olaniyi et al. [16] in Nigeria.
In our study the drug related side effects were noted in 43
cases (30.8%). ATT induced hepatitis was seen in 23 (16.5%)
of the cases, and hyperuricemia in 8 (5.7%). Gastritis in 7
(5.04%), nausea/vomiting 4 (2.88%), and neuropsychiatric 1
(0.72%) (Table 7). Our study is consistent with a study con-
ducted by Omar Kherad et al. [4], who found drug related side
effects in 75 (30%) of cases, and was in concordance Denise
Eri Onodera Vieira et al. [17].
The treatment outcome of our study revealed that, 64
(88.8%) of cases were cured, 8 (11.1%) were on treatment
and they are on follow up, there were no relapse case nor
any defaulter in our study (Table 6). Mengistu Endris et al.
found in his study, the overall ﬁve year treatment success rate
of the TB patients was 94.8%, slightly higher as compared to
our study because the total number of patients in there study
was 400 [6], comparable to other study conducted by Gebret-
sadik Berhe et al. [5].
In our study 36 (50%) of the cases had underlying comor-
bidity, hypertension 15 (20.8%) and diabetes 7 (9.7%) were
most common Table 8. The study conducted by Nissapatorn
et al. [18] found that lungs were the most common location
(91.4%) in tuberculosis with diabetes.
In our study the common USG ﬁndings were pleural effu-
sion 11 (23.9%), ascites 6 (17.6%), hepatosplenomegaly 11
(35.5%), abdominal lymphadenopathy in 4 (18.2%), omental
thickening 2 (25.0%), and cervical LAP 3 (9.1%) of cases (p
valve 0.0001).
The common CT ﬁndings in our study were: mediastinal
lymphadenopathy was seen in 13 (32.5%) of cases, pleural
effusion 7 (17.9%) of cases (p valve 0.009), cavitary lesionsin 27 (87.1%) of cases (p valve 0.0001), consolidation 30
(45.5%) of cases (p valve 0.047), abdominal LAP 5 (17.0%)
of cases (p valve 0.023), and omental thickening 2 (1.8%) of
cases (p valve 0.034).
The most common CT ﬁndings in a study conducted by
Gina Conchari Cabrer et al. [19] were consolidation (63%),
micronodules (58%), mediastinal LAP (47%), pleural effusion
(31%), and cavitation 4 (21%).
Conclusion
Disturbing fact from this study reveals that tuberculosis
haunts younger productive age, in an age group of 20–40 years
(62%) with most patients being from rural area where poverty,
ignorance and lack of adequate health facility still prevail. Due
to the low prevalence of HIV in Kashmir association with HIV
was low. Commonest presentation was fever, cough and
hemoptysis. Most patients have a good response and the most
common drug related side effect was hepatitis and is quite
prevalent in our community which further needs to be assessed
in larger studies especially with regard to genetic aspects.
The present study revealed that noncompliance is not a
pressing issue and the level of resistance is low in our commu-
nity. Response rate of daily regimen seems to be better
although it needs to be further studied in larger studies.
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